Vitalhub Corp. (TSE:VHI - Get Free Report)'s stock price traded up 0.7% during trading on Tuesday . The stock traded as high as C$9.31 and last traded at C$9.25. 79,716 shares changed hands during mid-day trading, a decline of 35% from the average session volume of 123,395 shares. The stock had previously closed at C$9.19.
Wall Street Analyst Weigh In
Separately, Cormark boosted their target price on shares of Vitalhub from C$9.50 to C$10.50 and gave the stock a "buy" rating in a research note on Wednesday, October 2nd.
Check Out Our Latest Analysis on VHI
Vitalhub Stock Up 2.8 %
The stock has a market cap of C$483.58 million, a P/E ratio of 86.45, a P/E/G ratio of 1.18 and a beta of 1.26. The company's 50 day moving average price is C$8.80 and its 200-day moving average price is C$7.73.
Vitalhub (TSE:VHI - Get Free Report) last released its earnings results on Thursday, August 8th. The company reported C($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of C$0.06 by C($0.07). Vitalhub had a net margin of 8.14% and a return on equity of 4.73%. The company had revenue of C$16.24 million for the quarter, compared to analyst estimates of C$15.39 million. Equities research analysts anticipate that Vitalhub Corp. will post 0.2296467 earnings per share for the current year.
About Vitalhub
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Featured Articles
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
